Doxepin
Back to searchMolecule Structure
Scientific Name
Doxepin
Description of the Drug
Doxepin is a psychotropic agent used for the treatment of depression, anxiety, manic-depressive disorder, and insomnia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01142
http://www.drugbank.ca/drugs/DB01142
Brand Name(s)
Sinepin, Sinequan
Company Owner(s)
New River Pharmaceuticals Inc, Lannett Co Inc, Watson Laboratories Inc, Pharmaceutical Assoc Inc, Taro Pharmaceutical Industries Ltd, Par Pharmaceutical Inc, Rk Pharma Inc, Contract Pharmacal Corp, Amneal Pharmaceuticals Co Gmbh, Purepac Pharmaceutical Co
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Norepinephrine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL222 |
Clinical Trial(s)
Unichem Links
Atlas | adapin | |||
SureChEMBL | SCHEMBL28054 | |||
Human Metabolome Database | HMDB0015273 | |||
DrugBank | DB01142 | |||
PubChem | 3158 | |||
LINCS | LSM-2803 | |||
DrugCentral | 956 | |||
rxnorm | DOXEPIN | SILENOR | ZONALON | DOXEPIN HYDROCHLORIDE |
KEGG Ligand | C06971 | |||
ChEBI | 4710 |